Sodium Glucose Cotransporter 2 Inhibition by Canagliflozin Attenuates Intrarenal Angiotensinogen Augmentation in Type 2 Diabetes Mellitus.

被引：0

作者：

Woods, T. Cooper ^{[1
]}

Satou, Ryousule ^{[1
]}

Miyata, Kayoko ^{[1
]}

Katsurada, Akemi ^{[1
]}

Dugas, Courtney M. ^{[1
]}

Lightell, Daniel, Jr. ^{[1
]}

Navar, L. Gabriel ^{[1
]}

机构：

[1] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA

来源：

HYPERTENSION | 2017年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

AP464

引用

页数：2

共 50 条

[1] Canagliflozin, an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus
Lamos, Elizabeth M.
Younk, Lisa M.
Davis, Stephen N.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (06) : 763 - 775
[2] Beneficial Effects of Sodium Glucose Cotransporter 2 Inhibition by Canagliflozin Independent of its Glucose Lowering Effects in Type 2 Diabetes Mellitus
Woods, T. Cooper
Sato, Ryosuke
Miyata, Kayoko
Katsurada, Akemi
Lightell, Daniel
Navar, L. Gabriel
FASEB JOURNAL, 2017, 31
[3] Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus
Woods, T. Cooper
Satou, Ryousuke
Miyata, Kayoko
Katsurada, Akemi
Dugas, Courtney M.
Klingenberg, Natasha C.
Fonseca, Vivian A.
Navar, L. Gabriel
AMERICAN JOURNAL OF NEPHROLOGY, 2019, 49 (04) : 331 - 341
[4] Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus
Abdul-Ghani, Muhammad A.
Norton, Luke
DeFronzo, Ralph A.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2015, 309 (11) : F889 - F900
[5] CANAGLIFLOZIN Sodium/Glucose Cotransporter 2 Inhibitor Treatment of Type 2 Diabetes Treatment of Obesity
Chao, E. C.
DRUGS OF THE FUTURE, 2011, 36 (05) : 351 - 357
[6] Sodium–glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
André J. Scheen
Nature Reviews Endocrinology, 2020, 16 : 556 - 577
[7] Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus
Raskin, Philip
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2013, 29 (05) : 347 - 356
[8] Blockade of Sodium Glucose Cotransporter 2 by Canagliflozin Suppresses High Glucose-induced Angiotensinogen Augmentation in Renal Proximal Tubular Cells
Satou, Ryousuke
Woods, T. Cooper
Miyata, Kayoko
Cypress, Michael W.
Katsurada, Akemi
Dugas, Courtney M.
Lightell, Daniel
Navar, L. Gabriel
HYPERTENSION, 2017, 70
[9] Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
Scheen, Andre J.
NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (10) : 556 - 577
[10] Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
Vivian, Eva
DIABETES EDUCATOR, 2015, 41 : 5S - 18S

← 1 2 3 4 5 →